Company intelligence / Profile preview
Huiyu Kangcheng
Unknown, Zhejiang, Chinaen.huiyupharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Huiyu Kangcheng (Zhejiang) Pharmaceutical Technology Co., Ltd. is a private Chinese pharmaceutical and biotech company founded in 2018, based in Zhejiang Province, China. The company focuses on oncology drug development, with a pipeline that includes both small molecules and monoclonal antibodies targeting cancer indications such as neoplasms. Its most advanced disclosed asset is in Phase 1 clinical trials as of early 2025, with another program at the discovery stage. The company's known target is PD-1, a well-established immuno-oncology checkpoint target.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeMonoclonal antibody
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Huiyu Kangcheng.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huiyu Kangcheng.